Biglycan deficiency interferes with ovariectomy-induced bone loss. - Wikidata - wikimedia - TriplyDB

Biglycan deficiency interferes with ovariectomy-induced bone loss.

Biglycan deficiency interferes with ovariectomy-induced bone loss.

http://www.wikidata.org/entity/Q53908803

about

The biology of small leucine-rich proteoglycans in bone pathophysiology Vibrational spectroscopic imaging for the evaluation of matrix and mineral chemistry The G-protein-coupled receptor GPR103 regulates bone formation.Biglycan deletion alters adiponectin expression in murine adipose tissue and 3T3-L1 adipocytes.The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3 Molecular genetic studies of gene identification for osteoporosis: a 2004 update.Plasminogen activator inhibitor-1 is involved in streptozotocin-induced bone loss in female mice.Potential roles for the small leucine-rich proteoglycans biglycan and fibromodulin in ectopic ossification of tendon induced by exercise and in modulating rotarod performance.A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cells.Presence of pyrophosphate in bone from an atypical femoral fracture site: A case report.Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy.Implications of combined ovariectomy and glucocorticoid (dexamethasone) treatment on mineral, microarchitectural, biomechanical and matrix properties of rat bone.Aging Versus Postmenopausal Osteoporosis: Bone Composition and Maturation Kinetics at Actively-Forming Trabecular Surfaces of Female Subjects Aged 1 to 84 Years.Evidence for a Role for Nanoporosity and Pyridinoline Content in Human Mild Osteogenesis Imperfecta.Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular Surfaces.Transmenopausal changes in trabecular bone quality

P2860

Q26861290-7A74A9E4-061C-48A8-B807-5B1E850BA661 Q28393488-7DB42F13-F8F6-4563-98E3-7878FD7FE895 Q34301986-580419BC-88B2-429B-8DBE-CE02E1E7AE57 Q34494135-846BC31A-DFEF-4534-AD20-164F4F653578 Q35175576-F3395732-9BF1-4D22-B93E-A7AB51B8A75A Q35691688-5EF347FA-A2F0-4563-BD98-5F8258395F53 Q37110567-45BA76DE-38D4-4B8E-AEB3-156567A7AADA Q37340261-A5973AF2-4A49-4A9D-9D60-AAE41F1FB70C Q37700278-C56ECB41-4695-46C5-B4FE-A28E34113628 Q37720674-31FCA121-C80D-4DD8-90A0-DDC07058925B Q43689965-1A621616-1571-4495-B3B1-B084C3F0E6C7 Q46284190-832AA678-B3F6-4A73-86F0-7FA869E60842 Q46909890-AD4DC7E8-3333-403A-89FC-73A2221B3D81 Q50992204-4AD25B61-19DE-4881-86EC-74BEC88ADA09 Q53215245-E315EDEB-D16E-4E0F-837E-31EE37F9E219 Q53704026-C4C43DA8-344C-4D77-80E7-7AEEA9215D68 Q57164616-5DE7E7AB-D610-4344-9D0B-B9D5E21DA2DF

P2860

Biglycan deficiency interferes with ovariectomy-induced bone loss.

http://www.wikidata.org/entity/Q53908803

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@en

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@nl

type

label

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@en

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@nl

prefLabel

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@en

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@nl

P1433

Q53908803-B01373F9-28EA-4FDD-ACA9-570D3E04A7D7

P1476

Q53908803-09F43494-D22E-40BB-90FD-8E23CD9DB85C

P2093

Q53908803-3E9B1E3C-3D5F-4D30-BE21-C4C14D09577C

Q53908803-675AADD9-A640-4DED-9812-D0DEAF489094

Q53908803-9E2358A3-E70A-40B2-8743-3A780F306E4C

Q53908803-C6FEB5A8-0A8B-4750-9EDE-26E438945933

Q53908803-D17F1188-84B6-4B63-A972-A49E1A019776

Q53908803-D7D37739-ABFF-4A36-AD56-314ED7E87F94

P2860

Q53908803-00307C96-0057-40CE-B631-1C01413A2D39

Q53908803-0F87A7E1-711D-43B2-8DD3-2EFBA858F8F0

Q53908803-133C4972-E807-412B-80FF-28565165DD49

Q53908803-3118D500-D836-42F8-B61A-09723ECC8932

Q53908803-3B713155-69BD-4E33-9575-797D684822D5

Q53908803-3C862D3C-EA93-4F31-A98C-2BBA3694EDA7

Q53908803-4A5DF8EC-257C-4FF2-BAA0-A627C8C169B9

Q53908803-520ADE6D-1C31-446D-ADB6-1CA45F616CF1

Q53908803-53DAE470-FE10-4075-9967-8B153228EB1B

Q53908803-548FBB6C-70BA-41F0-9145-C61BF3F9BD2E

P304

Q53908803-B49AE5BC-45FF-42C4-9E5C-9614FB76A0B2

P31

Q53908803-81E48882-B62F-4074-80A9-AEF356B61710

P356

Q53908803-D683425F-7239-4286-ADAF-81615B36D385

P433

Q53908803-12272EE3-4E13-41BD-BC00-3A0BB910614C

P478

Q53908803-3F9A6203-477C-4817-9F38-C1C83E2C6F66

P50

Q53908803-3B561235-974B-481D-A148-F4DC63A17761

Q53908803-E89EBCF7-1A39-41FD-97CE-35B6AA145453

P577

Q53908803-E26034CD-34EC-472D-925B-EAC035C70046

P5875

Q53908803-67458BE0-C6C7-4646-B873-53B4FF085CB0

P698

Q53908803-BDD2E6D9-2AB5-4BC1-8D11-D1E3FCD89BBB

P356

JBMR.2003.18.12.2152

P1433

Journal of Bone and Mineral Research

P1476

Biglycan deficiency interferes with ovariectomy-induced bone loss.

@en

P2093

Hans S Poulsen

http://www.w3.org/2001/XMLSchema#string

Karina L Nielsen

http://www.w3.org/2001/XMLSchema#string

Marian F Young

http://www.w3.org/2001/XMLSchema#string

Susan A Bloomfield

http://www.w3.org/2001/XMLSchema#string

Thomas L Andersen

http://www.w3.org/2001/XMLSchema#string

Xiao-Dong Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins

Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival

Super-motifs and evolution of tandem leucine-rich repeats within the small proteoglycans--biglycan, decorin, lumican, fibromodulin, PRELP, keratocan, osteoadherin, epiphycan, and osteoglycin

Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively

Interaction of biglycan with type I collagen

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

P304

2152-2158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.2003.18.12.2152

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Marie Heegaard

Matthew R. Allen

P577

2003-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8962881

http://www.w3.org/2001/XMLSchema#string

P698

14672350

http://www.w3.org/2001/XMLSchema#string